Alterations in the complement cascade in post-traumatic stress disorder

Allergy, Asthma and Clinical Immunology

Volumn 6, Issue 1, 2010, Pages

  Hovhannisyan, Lilit P ^a   Mkrtchyan, Gohar M ^a   Sukiasian, Samvel H ^b   Boyajyan, Anna S ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Armenia)

^b Stress Centre of the Ministry of Labour and Social Affairs   (Armenia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DISORDER; COMPLEMENT SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEMOLYSIS; HUMAN; HYDROLYSIS; MALE; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; SERUM;

EID: 79960540049     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-6-3     Document Type: Article

References (43)

1. Subtle presentations of post-traumatic stress disorder: diagnostic issues. Jacobs WJ, Dalenberg C, Psychiatr Clin North Am 1998 21 4 835 845 10.1016/S0193-953X(05)70044-7 9890125 (Pubitemid 28560022)
2. Post-traumatic stress disorder sourcebook. Schiraldi GR, McGraw-Hill Companies: Columbus 2000
3. Post-traumatic stress disorder. Connor MD, Butterfield MI, FOCUS 2003 1 3 247 262
4. PTSD following terrorist attacks: a prospective evaluation. Shalev AY, Freedman S, Am J Psychiatry 2005 162 6 1188 1191 10.1176/appi.ajp.162.6.1188 15930068 (Pubitemid 40770703)
5. Post traumatic stress disorder: the invisible injury. Kinchin D, Success Unlimited: UK 2005
6. Study identifies gene x environment link to PTSD. Gitlin JM, JAMA 2008 299 11 1291 1305 10.1001/jama.299.11.1291 18349090 (Pubitemid 351439075)
7. Post-traumatic stress disorder: advances in psychoneuroimmunology. Wong CM, Psychiatr Clin North Am 2002 25 2 369 383 10.1016/S0193-953X(01)00006-5 12136505 (Pubitemid 34761242)
8. Immune function in PTSD. Altemus M, Dhabhar FS, Yang R, Ann NY Acad Sci 2006 1071 167 183 10.1196/annals.1364.013 16891569 (Pubitemid 44126727)
9. Elevated levels of serum interleukin-1b in combat-related posttraumatic stress disorder. Spivak B, Shohat B, Mester R, Avraham S, Gil-Ad I, Bleich A, Valevski A, Weizman A, Biol Psychiatry 1997 42 5 345 348 10.1016/S0006-3223(96) 00375-7 9276074 (Pubitemid 27380968)
10. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Maes M, Lin A, Delmeire L, Maes M, Lin AH, Bonaccorso S, Goossens F, Van Gastel A, Pioli R, Delmeire L, Scharpé S, Biol Psychiatry 1999 45 7 833 839 10.1016/S0006-3223(98)00131-0 10202570 (Pubitemid 29185473)
11. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Baker DG, Ekhator NN, Kasckow JW, Dashevsky B, Horn PS, Bednarik L, Geracioti TD, Neuroimmunomodulation 2001 9 209 217 10.1159/000049028 11847483 (Pubitemid 34195779)
12. Suppression of cellular immunity in men with a past history of posttraumatic stress disorder. Kawamura N, Kim Y, Asukai N, Am J Psych 2001 158 484 486 10.1176/appi.ajp.158.3.484 (Pubitemid 32205210)
13. C-reactive protein and interleukin- 6 receptor in post-traumatic stress disorder: a pilot study. Miller RJ, Sutherland AG, Hutchison JD, Alexander DA, Cytokine 2001 13 253 255 10.1006/cyto.2000.0825 11237435 (Pubitemid 32575458)
14. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Tucker P, Ruwe WD, Masters B, Biol Psychiatry 2004 56 121 128 10.1016/j.biopsych.2004. 03.009 15231444 (Pubitemid 38844787)
15. Inflammation as a cardiovascular risk factor. Willerson JT, Ridker PM, Circulation 2004 109 21 Suppl 1 2 10 14707015
16. Myocardial infarction and post-traumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Gander ML, von Kanel R, Eur J Cardiovasc Prev Rehabil 2006 13 165 172 10.1097/01.hjr.0000214606.60995.46 16575268 (Pubitemid 44097719)
17. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. Von-Kanel R, Hepp U, Kraemer B, Traber R, Keel M, Mica L, Schnyder U, Psychiatr Res 2007 41 9 744 752 10.1016/j.jpsychires. 2006.06.009 (Pubitemid 46659723)
18. Serine proteases of the complement system. Sim RB, Laich A, Biochem Soc Trans 2000 28 545 550 11044372
19. Beyond lysis: how complement influences cell fate. Cole DS, Morgan BP, Clin Sci 2003 104 5 455 466 10.1042/CS20020362 12580763 (Pubitemid 36628141)
20. A regulatory role for complement in innate immunity and autoimmunity. Nauta AJ, Roos A, Daha MR, Int Arch Allergy Immunol 2004 134 4 310 323 10.1159/000079261 15218334 (Pubitemid 39070165)
21. Physiologic role of the complement system in host defense, disease, and malnutrition. Sakamoto M, Fujisawa Y, Nishioka K, Nutrition 1998 14 4 391 398 10.1016/S0899-9007(97)00473-5 9591312 (Pubitemid 28222238)
22. The human complement system in health and disease. Volankis JE, Frank MM, Mircel Dekker Inc; New York 1998
23. Complement in inflammatory tissue damage and disease. Mollnes TE, Song W-C, Lambris JD, Trends Immunol Today 2002 23 2 61 66 10.1016/S1471-4906(01) 02129-9 (Pubitemid 34310141)
24. The role of complement in disorders of the nervous system. Morgan BP, Gasque P, Singhrao SK, Piddlesden SJ, Immunopharmacology 1997 38 1-2 43 50 10.1016/S0162-3109(97)00059-3 9476113 (Pubitemid 28049962)
25. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Yasojima K, Schwab C, McGeer EG, McGeer PL, Amer J Pathol 1999 154 3 927 936 (Pubitemid 29122612)
26. Complement components of the innate immune system in health and disease in the CNS. Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP, Immunopharmacology 2000 49 1-2 171 186 10.1016/S0162-3109(00)80302-1 10904116 (Pubitemid 30445228)
27. Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities. Gasque P, Neal JW, Gasque P, Neal JW, Singhrao SK, McGreal EP, Dean YD, Van BJ, Morgan BP, Mol Neurobiol 2002 25 1 1 17 10.1385/MN:25:1:001 11890454 (Pubitemid 34165501)
28. Innate immunity and brain inflammation: the key role of complement. Francis K, Van Beek J, Canova C, Neal JW, Gasque P, Expert Rev Mol Med 2003 5 15 1 19 10.1017/S1462399403006252 14585169
29. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Van Beek J, Elward K, Gasque P, Ann N Y Acad Sci 2003 992 56 71 10.1111/j.1749-6632.2003.tb03138.x 12794047 (Pubitemid 36706637)
30. Classical pathway complement activity in schizophrenia. Hakobyan S, Boyajyan A, Sim RB, Neurosci Lett 2005 374 1 35 37 10.1016/j.neulet.2004.10.024 15631892 (Pubitemid 41556543)
31. Hyperactivation of the alternative complement cascade in schizophrenia. Boyajyan AS, Khoyetsyan AG, Hakobyan SS, Dokl Biochem Biophys (Moscow) 2008 419 56 57 10.1134/S1607672908020026 (Pubitemid 351641357)
32. The complement system in schizophrenia. Mayilyan KR, Weinberger DR, Sim RB, Drug News Perspect 2008 21 4 200 210 10.1358/dnp.2008.21.4.1213349 18560619
33. Effects of psychological stress on serum immunoglobulin, complement, and acute phase protein concentrations in normal volunteers. Maes M, Hendriks D, Van Gastel A, Demedts P, Wauters A, Neels H, Janca A, Scharpé S, Psychoneuroendocrinology 1997 22 397 409 10.1016/S0306-4530(97)00042-5 9364619 (Pubitemid 27431503)
34. Complement cascade activation after an acute psychological stress task. Burns V, Edwards K, Ring C, Drayson M, Carroll D, Psychosomatic Medicine 2008 70 387 396 10.1097/PSY.0b013e31816ded22 18480187
35. Structured clinical interview for the DSM-IV axis I disorders (SCID PTSD Module). First MB, Spitzer RL, Gibbon M, Williams JB, National Center for PTSD; USA 1996
36. The development of a clinician administered PTSD scale. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM, J Trauma Stress 1995 8 1 75 90 10.1002/jts.2490080106 7712061
37. Haemolytic assays for whole complement activity and individual components. Whaley K, North J, Complement. A practical approach Oxford: Oxford University Press, Doods AW, Sim RB, 1997 19 47
38. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates. Morgan BP, Complement methods and protocols: Methods in molecular biology Totowa, NJ: Humana Press, Morgan BP, 2000 61 71 full-text
39. Psychobiologic predictors of disease mortality after psychological trauma. Boscarino J, J Nerv Ment Dis 2008 196 100 107 10.1097/NMD. 0b013e318162a9f5 18277217 (Pubitemid 351253421)
40. Hypothalamic-pituitaryadrenal dysfunction in posttraumatic stress disorder. Yehuda R, Giller EL, et al. Biol Psychiatry 1991 30 1031 1048 10.1016/0006-3223(91)90123-4 1661614
41. Psychoneuroendocrinology of post-traumatic stress disorder. Yehuda R, Psychiatr Clin North Am 1998 21 359 379 10.1016/S0193-953X(05)70010-1 9670231 (Pubitemid 28311856)
42. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. McEwen BS, Biron CA, Brunson KW, Brain Res Rev 1997 23 79 133 10.1016/S0165-0173(96)00012-4 9063588 (Pubitemid 27090751)
43. Role of endocrine and inflammatory alterations in comorbid somatic diseases of post-traumatic stress disorder. Rohleder N, Karl A, Minerva Endocrinol 2006 31 273 288 17213794